but a protective effect was noted for stomach cancer, liver cancer, and lymphoma and an increased risk for both
Statins should not be taken if you have liver disease or if blood tests suggest that your liver may not be working properly
Google Scholar; However, few studies have examined the association between postdiagnosis statin use and the risk of mortality in HCC patients
However, recent experimental and clinical studies indicate the potential use of statins in treating liver cancer
Primary liver cancer is the fourth leading cause of cancer-related deaths , and a nationwide study of statin use in patients with HF reported a lower risk of cancer incidence and cancer-related mortality
It’s also Use of statins is associated with a reduced risk of hepatocellular carcinoma (HCC)
To date, there is no conclusive evidence that links MSG consumption to cancer, either as a cause of cancer or as increasing the risk of cancer
It may be given to you for other reasons
[ 23, 27] Based on the reports from Still, in one trial, the CARE trial, breast cancer rates of those taking a statin went up 1500 percent
doi: 10
Aim: To investigate the causal relationship of serum lipid indicators and lipid-lowering drugs with the risk of liver cancer using Mendelian randomization study
6,34 For cancer types other than liver and biliary cancer, 35 a plausible Hepatocellular carcinoma (HCC) is one of the most common primary malignant tumors worldwide and according to global cancer statistics (2018), liver cancer is the fourth leading cause of cancer deaths [1,2,3]
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials
Hepatocellular carcinoma (HCC) is a frequent primary aggressive cancer, a crucial cause of cancer-related mortality globally